Weight Loss · Reference
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
This page covers what EUPHORIA is next to a GLP-1, where the two meet, the symptoms that could come from either, how the schedules fit, who should discuss it first, and how to add EUPHORIA properly. EUPHORIA is not a weight treatment and not a treatment for GLP-1 side effects.
EUPHORIA can be prescribed alongside tirzepatide or semaglutide when a physician reviewing your intake judges it appropriate, but no study has tested the blend with a GLP-1, and the blend itself has never been studied as a blend. None of its four components, MOTS-c, BPC-157, GHK-Cu and kisspeptin-10, acts on the GLP-1 or GIP receptor or on appetite, so EUPHORIA does a different job from tirzepatide rather than adding to it. The points that matter are practical: MOTS-c and tirzepatide both point toward lower blood sugar, both can nudge heart rate, kisspeptin and the GLP-1 can both cause nausea, and kisspeptin and tirzepatide both touch fertility and contraception planning. Everything on this page applies to semaglutide the same way.
This page covers what EUPHORIA is next to a GLP-1, where the two meet, the symptoms that could come from either, how the schedules fit, who should discuss it first, and how to add EUPHORIA properly. EUPHORIA is not a weight treatment and not a treatment for GLP-1 side effects.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
The short answer
| Question | Answer |
|---|---|
| Can they be prescribed together? | Yes, when a physician reviewing your intake judges it appropriate |
| Has the combination been studied? | No. Neither EUPHORIA with a GLP-1, nor EUPHORIA's four components together |
| Does any component act on appetite? | No |
| Does EUPHORIA add weight loss? | No study shows that; MOTS-c has no human trials at all |
| Is there an established interaction? | No interaction list exists for EUPHORIA or any of its components |
| What overlaps? | Blood sugar, heart rate, nausea, and fertility and contraception planning |
| What belongs on the intake? | Glucose-lowering medication, testosterone therapy, hormone-sensitive conditions, contraception, copper disorders, cancer history |
| Same answer for semaglutide? | Yes |
The medications this page covers:
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| EUPHORIA Blend | 5 mL multi-dose vial: MOTS-c 2 mg/mL, BPC-157 2 mg/mL, GHK-Cu 10 mg/mL, kisspeptin-10 0.4 mg/mL (10 mg / 10 mg / 50 mg / 2 mg per vial) | 0.25 mL (25 units) under the skin once daily Monday through Friday | $279/mo |
| Tirzepatide | Dose-specific 2 mL vials at six strengths, 2.5 mg to 15 mg weekly; glycine in the 2.5 mg and 7.5 mg vials | 0.50 mL (50 units) once weekly at every strength | From $159/mo |
| Semaglutide | Dose-specific vials at six strengths | Printed on the vial for your strength | From $99/mo |
Prices are all-in, covering medication, physician review, refill management and shipping, with no membership fee. GLP-1 prices are "from" prices, set by dose. Compounded medications are not FDA approved.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
What EUPHORIA is, next to a GLP-1
Tirzepatide is a single peptide that activates the GIP and GLP-1 receptors. It acts on appetite centres in the brain, slows gastric emptying, and changes insulin and glucagon signalling (what is tirzepatide). EUPHORIA is four separately studied peptides dissolved in one vial, each with its own literature and its own regulatory file (what is the EUPHORIA blend). By mass it is mostly GHK-Cu: 50 of the 72 mg.
| Component | Per 25 unit dose | What it is described to do | Human evidence | Relation to tirzepatide |
|---|---|---|---|---|
| MOTS-c | 0.5 mg | AMPK activation and fuel handling in muscle (mice) | No randomised trials; observational data only | Both point toward lower glucose |
| BPC-157 | 0.5 mg | Angiogenesis, tendon cell migration, gut-lining protection in animals | Early-phase work for inflammatory bowel indications | No shared pathway |
| GHK-Cu | 2.5 mg | Collagen and matrix synthesis, copper delivery | Small topical skin studies only | No shared pathway |
| Kisspeptin-10 | 0.1 mg | Prompts the body's own reproductive hormone axis | Small studies, mostly kisspeptin-54 by infusion | Both touch fertility planning |
None of the four binds the GIP or GLP-1 receptor or is described as acting on appetite or gastric emptying. That makes a direct pharmacological interaction with tirzepatide unlikely on mechanism. With no study of the pairing, that is the limit of what can be said, and it is not the same as evidence that the combination is safe.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
Where EUPHORIA and a GLP-1 meet
Blood sugar
This is the main practical point, and it comes from the MOTS-c component. In the 2015 Cell Metabolism work, MOTS-c in mice was reported to prevent age-related insulin resistance and the insulin resistance that develops on a high-fat diet. That has never been tested in people, but the mechanism points toward lower glucose. Tirzepatide amplifies insulin release only when glucose is high, so on its own it rarely causes low blood sugar (under 2 percent in SURPASS-2), though the risk rises with insulin or a sulfonylurea.
If you What it means Take no glucose-lowering medication Low blood sugar is uncommon on either; know the signs anyway Take insulin or a sulfonylurea Say so at intake; both MOTS-c's mechanism and tirzepatide point toward lower glucose Feel shaky, sweaty or confused Treat it the way you have been taught, then report it the same day Never change your diabetes medication on your own. Your physician sets your directions after reviewing your intake, and any change is printed on your vial.
Heart rate
Some people describe jitteriness or a faster pulse in the hour or two after a dose early in a EUPHORIA course, attributed to MOTS-c, which usually settles. On the GLP-1 side, the semaglutide label reports resting heart rate rising by an average of 1 to 4 beats per minute against placebo, and the tirzepatide label asks for heart rate to be checked at routine intervals. A heart that races at rest should be reported on either.
Nausea, flushing and headache
Nausea is the most common tirzepatide side effect, reported by 25 to 29 percent of adults on the approved weight-management label against 8 percent on placebo, and it clusters after starting and after each dose increase. On EUPHORIA, kisspeptin-10 is reported to cause occasional nausea, brief flushing and early headache, and some people report early nausea or light-headedness with the blend. Two sources of queasiness in the same weeks are hard to tell apart, which is the main reason to start EUPHORIA when your GLP-1 dose is steady, not in the same week as an increase. Managing GLP-1 nausea is covered in GLP-1 nausea: how to manage it.
Fertility and contraception
This is the point people miss. Kisspeptin acts directly on the reproductive axis, and EUPHORIA is not used in pregnancy, breastfeeding or when trying to conceive. On the GLP-1 side, weight reduction can restore ovulation in people who had stopped ovulating, and tirzepatide can reduce how well oral contraceptives are absorbed for four weeks after starting and after each dose increase; the label advises a non-oral method or an added barrier method in those windows.
Fact Comes from What it means for you Weight reduction can restore ovulation GLP-1 medications Pregnancy is possible even if it was not before Oral contraceptives may be absorbed less reliably in the dose-change windows Tirzepatide Raise your contraception at intake Kisspeptin is not used in pregnancy, breastfeeding or when trying to conceive EUPHORIA Tell your physician about any pregnancy plans Pregnancy rules out tirzepatide and semaglutide GLP-1 medications Tell your physician and care team straight away If you are pregnant, trying to conceive, or think you might be, tell your physician and care team through your account before your next dose, and do not change or stop anything on your own. More is in do peptides affect fertility and can you take peptides while pregnant.
Stomach side effects: EUPHORIA is not the fix
People sometimes ask whether the BPC-157 in EUPHORIA will settle tirzepatide's stomach effects. BPC-157's gut literature is animal work, and GLP-1 nausea, reflux and constipation come from slowed gastric emptying. They are a dose and titration question for the prescribing physician, not a reason to add a second vial.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
Symptoms that could come from either
| Symptom | On tirzepatide | On EUPHORIA |
|---|---|---|
| Nausea | The most common effect, around starting and dose increases | Occasional, attributed to kisspeptin; early nausea reported for the blend |
| Dizziness or light-headedness | 4 to 5 percent on the label, against 2 percent | Some people early on |
| Faster pulse | Resting heart rate can rise slightly | Some people after a dose, attributed to MOTS-c |
| Flushing or headache | Headache appears on GLP-1 lists | Brief flushing and early headache, attributed to kisspeptin |
| Injection-site redness or bruising | 6 to 8 percent on the label | The most common report |
| Faint blue tint at the site | No | Possible, from the copper in GHK-Cu |
| Reflux, constipation, diarrhea | Common around dose increases | Not described |
The full side-effect references are tirzepatide side effects and EUPHORIA blend side effects.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
Fitting the schedules together
| EUPHORIA | Tirzepatide | |
|---|---|---|
| Draw | 0.25 mL (25 units on a U-100 insulin syringe) | 0.50 mL (50 units) |
| Medication per dose | 0.5 mg MOTS-c, 0.5 mg BPC-157, 2.5 mg GHK-Cu, 0.1 mg kisspeptin-10 | Your weekly strength, 2.5 mg to 15 mg |
| How often | Once daily Monday through Friday, weekends off | Once weekly, same day each week |
| Doses per vial | 20 | 4 |
| One vial lasts | About four weeks | Four weeks |
The EUPHORIA figures are math from the vial: 0.25 mL carries a quarter of each component's per-mL concentration, and 5 mL at 0.25 mL is 20 doses. The weekend gap is deliberate, because kisspeptin's response fades under continuous exposure. Both run on a 28-day refill cycle, one vial per fill.
- Two vials, two syringes, two sites. Never mix EUPHORIA and tirzepatide in one syringe; each vial's directions were calculated against that vial's concentration.
- Keep your tirzepatide day fixed. On a shared weekday, inject each at a different site.
- Refrigerate both, and do not keep a multi-peptide vial past its beyond-use date.
The dose arithmetic is in EUPHORIA blend dosage and tirzepatide dosing chart.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
Who should discuss it first
| Situation | Why |
|---|---|
| Insulin or a sulfonylurea | MOTS-c's mechanism and tirzepatide both point toward lower glucose |
| Testosterone therapy | External testosterone suppresses the system kisspeptin acts on; kisspeptin is not used alongside it |
| Hormone-sensitive condition, including hormone-sensitive cancer | Kisspeptin stimulates sex-hormone production |
| Pregnancy, trying to conceive or breastfeeding | Neither EUPHORIA nor a GLP-1 is used |
| Oral contraceptive | Tirzepatide's absorption windows need planning |
| Personal or family history of medullary thyroid carcinoma or MEN 2 | Rules out tirzepatide and semaglutide |
| Wilson's disease or another copper-metabolism disorder | Rules out the GHK-Cu component |
| Personal history of cancer, or anticoagulants | Blood-vessel mechanisms of BPC-157 and GHK-Cu |
| Already on kisspeptin, MOTS-c, GHK-Cu or another blend containing them | EUPHORIA would duplicate components |
| Tested athlete | MOTS-c, BPC-157 and kisspeptin are on the WADA Prohibited List |
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
Semaglutide works the same way
Semaglutide acts at GLP-1 only, where tirzepatide acts at GLP-1 and GIP, but both reduce appetite and slow gastric emptying, both bring the same early stomach side effects, and both rarely cause low blood sugar on their own. Nothing on this page changes for semaglutide. Semaglutide and tirzepatide are never taken together; see semaglutide vs tirzepatide.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
What the evidence shows, honestly
Tirzepatide has a large human trial base in its approved form. EUPHORIA has never been studied as a blend; its evidence is per component and uneven: no human trials of MOTS-c, early-phase human work for BPC-157, small topical studies for GHK-Cu, and small kisspeptin trials that mostly used kisspeptin-54 by infusion. There is no study of EUPHORIA or any component with a GLP-1.
On regulation, kisspeptin-10 remains in Category 2 of the FDA's interim 503A list, where it was placed on 29 September 2023, and the FDA's advisory committee voted 0 to 11 against listing it in October 2024. BPC-157 and MOTS-c were removed from Category 2 in April 2026 and recommended for the 503A Bulks List by the committee in July 2026 (8 to 6 and 7 to 5); final determinations are pending. GHK-Cu is scheduled for review before the end of February 2027. The pairing is reasonable to discuss when there is a separate reason for EUPHORIA. It is not a stack shown to work better than tirzepatide alone. Related reading: can you take kisspeptin with tirzepatide and can you take MOTS-c with tirzepatide.
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?
How to add EUPHORIA to a GLP-1 properly
- Name the goal that is separate from weight, such as desire, energy or skin, so your physician can judge whether a four-component vial is the right tool or whether a single component fits better.
- List everything, including glucose-lowering medication, testosterone, contraception, supplements such as zinc, and any blend you already take.
- Start when your GLP-1 dose is steady, not in the same week as a dose increase.
- Report what happens, including nothing, through your account.
Your physician sets your directions after reviewing your intake, and every vial arrives with its directions printed on the label. More on combining is in what peptides can you take with tirzepatide and can you take two peptides together. Step by step: how to get tirzepatide prescribed, and for the components kisspeptin and MOTS-c.
References
What this is based on.
References
- Lee C, Zeng J, Drew BG et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance · Cell Metab (2015) · PMID 25738459
- Dhillo WS, Chaudhri OB, Patterson M et al.. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males · J Clin Endocrinol Metab (2005) · PMID 16174713
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration · Biomed Res Int (2015) · PMID 26236730
- Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine (2021) · PMID 33567185
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) · New England Journal of Medicine (2023) · PMID 37952131
- Wadden TA, Bailey TS, Billings LK, et al.. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3) · JAMA (2021) · PMID 33625476
- Rubino D, Abrahamsson N, Davies M, et al.. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial · JAMA (2021) · PMID 33755728
- Marso SP, Bain SC, Consoli A, et al.. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) · New England Journal of Medicine (2016) · PMID 27633186
- Davies M, Færch L, Jeppesen OK, et al.. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial · The Lancet (2021) · PMID 33667417
- Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial · Nature Medicine (2022) · PMID 36216945
- Rubino DM, Greenway FL, Khalid U, et al.. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial · JAMA (2022) · PMID 35015037
- Aronne LJ, Horn DB, le Roux CW, et al.. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) · New England Journal of Medicine (2025) · PMID 40353578
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Can You Take EUPHORIA Blend With Tirzepatide or Semaglutide?, answered.
It can be prescribed alongside tirzepatide when a physician reviewing your intake judges it appropriate. None of its components acts on the GLP-1 system, but no study has tested the combination.
The answer is the same as for tirzepatide.
No study shows that. MOTS-c has mouse work on fuel handling and no human trials, and no component acts on appetite. EUPHORIA is not a weight treatment.
There is no evidence that it does, and kisspeptin can itself cause occasional nausea. GLP-1 nausea is a dose and titration question for your physician.
Both point toward lower glucose, MOTS-c on its mouse mechanism and tirzepatide on its label. Low blood sugar is uncommon without insulin or a sulfonylurea. If you take either, say so at intake and report any shaky, sweaty or confused spell the same day.
Tirzepatide can reduce how well oral contraceptives are absorbed for four weeks after starting and after each dose increase. EUPHORIA does not change that, and its kisspeptin component is not used when trying to conceive. Raise your contraception at intake.
Yes, as two separate injections from two separate vials, each with its own syringe and at a different site.
No interaction is described, and no interaction list exists for EUPHORIA or its components because the trials have not been run. That is why the intake asks for every medication you take.
Neither has been studied with one. Kisspeptin alone is the cleaner choice when desire or hormone signalling is the whole goal; EUPHORIA adds MOTS-c, BPC-157 and GHK-Cu. The choice depends on your goal, not on the GLP-1.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.